Concepedia

Amy Lin

AL

Statistics

Publications

22

Citations

3.3K

H-Index

18

Active since

1999

Affiliations

Cornell University(Current)

University of Wisconsin–Madison

La Roche College

Virginia Commonwealth University Medical Center

Toronto Western Hospital

Amy Lin is an author at Cornell University specializing in viral hepatitis, antiviral therapy, and pharmacotherapy.

ORCID

Publications per year

1999–2020

22

Publications

22

Peginterferon Alfa-2a in Patients with Chronic Hepatitis C

Stefan Zeuzem, S.V. Feinman, J. Rasenack et al. · New England Journal of Medicine · 2000 · 1.2K citations · Full text

, , +14

Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and Cirrhosis

E. Jenny Heathcote, Mitchell L. Shiffman, W. Graham E. Cooksley et al. · New England Journal of Medicine · 2000 · 886 citations · Full text

, , +17

REDUCTION OF ACUTE RENAL ALLOGRAFT REJECTION BY DACLIZUMAB1

Susan Light, Ian R. Hardie, Amy Lin et al. · Transplantation · 1999 · 308 citations

, , +17

Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD)

Samuel S. Lee, E. Jenny Heathcote, K. Rajender Reddy et al. · Journal of Hepatology · 2002 · 133 citations

, , +16

RESULTS OF 3-YEAR PHASE III CLINICAL TRIALS WITH DACLIZUMAB PROPHYLAXIS FOR PREVENTION OF ACUTE REJECTION AFTER RENAL TRANSPLANTATION1

Ginny L. Bumgardner, Ian R. Hardie, Robert W. Johnson et al. · Transplantation · 2001 · 103 citations

, , +17

1–5 of 22